Hib-DTP-hepatitis-B vaccine - LG Chem
Alternative Names: DTwP-HB/Hib; DTwP-HepB-Hib (recon.); Euforvac-Hib; LBVF0101Latest Information Update: 08 Sep 2021
At a glance
- Originator LG Life Sciences
- Developer LG Chem; LG Life Sciences
- Class Antibacterials; Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 08 Sep 2021 Discontinued - Phase-III for Diphtheria (In children, In infants, Prevention) in China (IM)
- 08 Sep 2021 Discontinued - Phase-III for Diphtheria (In infants, Prevention, In volunteers) in India (IM)
- 08 Sep 2021 Discontinued - Phase-III for Haemophilus infections (In children, In infants, Prevention) in China (IM)